ArticleCureus2025
Exploring the Enigma of a Urachal Mucinous Cystic Tumor of Low Malignant Potential (MCTLMP): A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mucinous urachal neoplasms are rare and can present as benign cystadenomas, mucinous cystic tumors of low malignant potential (MCTLMPs), or invasive adenocarcinomas. MCTLMPs occupy a borderline category characterized by mild-to-moderate atypia and papillary/villous architecture without stromal invasion. Here, we describe a 54-year-old male patient who presented with persistent dysuria and was found to have a vesicourachal diverticulum. Surgical management involved a robot-assisted partial cystectomy with complete excision of the urachal remnant. Histopathologic examination revealed a multiloculated cystic lesion lined by mucin-producing epithelium, confirming an MCTLMP; immunohistochemical staining demonstrated intestinal differentiation (CK20+/CK7-/CDX2+) and absence of invasive features. p53 demonstrated wild-type expression, indicating no significant molecular alterations. The early postoperative course was uneventful, with no complications such as infection or urinary leakage. At the one-year follow-up, the patient experienced persistent urinary urgency, suprapubic discomfort, and scrotal pain, indicative of lower urinary tract dysfunction secondary to surgical intervention. No recurrence has been observed. This case underscores the importance of accurate histopathological evaluation, complete surgical resection, and vigilant long-term surveillance to prevent progression of urachal mucinous tumors. Further research into molecular markers may refine prognostication and guide future therapeutic strategies for these rare neoplasms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.